Skip to main content

Romano-Ward syndrome vs Jervell–Lange-Nielsen syndrome

Romano-Ward syndrome vs Jervell–Lange-Nielsen syndrome

Romano-Ward syndrome vs Jervell–Lange-Nielsen syndrome

A Detailed Clinical Review of Congenital Long QT Syndromes

Congenital Long QT Syndromes (LQTS) are inherited cardiac channelopathies characterized by delayed ventricular repolarization, leading to QT interval prolongation on ECG and a high risk of malignant ventricular arrhythmias. Among these, Romano–Ward syndrome and Jervell–Lange-Nielsen (JLN) syndrome represent two classic but clinically distinct entities.



---


Overview of Congenital Long QT Syndrome


LQTS results from mutations in genes encoding cardiac ion channels, primarily potassium and sodium channels. The hallmark is QT prolongation, predisposing patients to polymorphic ventricular tachycardia, especially Torsades de Pointes, which may degenerate into ventricular fibrillation and cause sudden cardiac death.


Common clinical manifestations include:


Syncope (often exercise- or stress-related)


Seizure-like episodes


Sudden cardiac arrest, particularly in young individuals




---


Romano–Ward Syndrome


Romano–Ward syndrome is the most common form of congenital LQTS.


Genetics and Inheritance


Inheritance pattern: Autosomal dominant


Most commonly affected genes:


KCNQ1 (LQT1)


KCNH2 (LQT2)


SCN5A (LQT3)




A single pathogenic variant is sufficient to produce the phenotype, and family history is often positive for syncope or sudden death.


Pathophysiology


Mutations lead to reduced outward potassium currents or persistent inward sodium current, causing delayed ventricular repolarization and QT prolongation.


Clinical Presentation


Onset: Childhood or adolescence


Symptoms:


Syncope during exercise or emotional stress


Palpitations


Sudden collapse triggered by swimming, exertion, or sudden auditory stimuli (especially LQT2)




Hearing is normal, which is a key distinguishing feature from JLN syndrome.


ECG Features


Prolonged corrected QT interval (QTc)


Normal QRS morphology


T-wave abnormalities depending on genotype



Risk Profile


Moderate to high risk of Torsades de Pointes


Sudden cardiac death risk varies by genotype and treatment adherence



Management


First-line therapy: Non-selective Ξ²-blockers (e.g., nadolol, propranolol)


Avoidance of QT-prolonging drugs


ICD implantation in high-risk patients (recurrent syncope, cardiac arrest, or Ξ²-blocker failure)



Prognosis


With early diagnosis and appropriate therapy, prognosis is generally good, and many patients live normal lives.



---


Jervell–Lange-Nielsen Syndrome


JLN syndrome represents the most severe form of congenital LQTS.


Genetics and Inheritance


Inheritance pattern: Autosomal recessive


Genes involved:


KCNQ1


KCNE1




Both alleles must be affected, typically inherited from asymptomatic carrier parents.


Pathophysiology


These genes are crucial for potassium ion transport in both the heart and inner ear. Severe loss of potassium channel function leads to:


Profound QT prolongation


Sensorineural deafness due to impaired endolymph potassium recycling



Clinical Presentation


Onset: Infancy or early childhood


Symptoms:


Early recurrent syncope


Seizures misdiagnosed as epilepsy


Sudden cardiac arrest at a young age




Congenital bilateral sensorineural deafness is universal and diagnostic.


ECG Features


Markedly prolonged QTc


Frequent ventricular ectopy


High susceptibility to Torsades de Pointes even with minimal triggers



Risk Profile


Very high risk of malignant arrhythmias


One of the highest sudden cardiac death risks among inherited arrhythmia syndromes



Management


Aggressive treatment required:


High-dose Ξ²-blockers


Early ICD implantation


Left cardiac sympathetic denervation in refractory cases



Multidisciplinary care including cardiology and audiology



Prognosis


Without early diagnosis and intervention, mortality is high in childhood. Early recognition dramatically improves survival.



---


Key Differences Between Romano–Ward and JLN Syndromes


Feature Romano–Ward Jervell–Lange-Nielsen


Inheritance Autosomal dominant Autosomal recessive

Hearing Normal Congenital deafness

QT prolongation Moderate to severe Markedly severe

Age of onset Childhood / adolescence Infancy

Sudden death risk Moderate–high Very high

Severity Milder LQTS phenotype Most severe LQTS




---


Clinical Importance of Differentiation


Correct differentiation between Romano–Ward and JLN syndromes is critical because:


Risk stratification differs significantly


Management intensity varies


Family screening and genetic counseling depend on inheritance pattern


Early cochlear implantation and audiologic support are essential in JLN




---


Conclusion


Romano–Ward syndrome and Jervell–Lange-Nielsen syndrome represent two ends of the congenital LQTS spectrum. While both share the same electrophysiological substrate of delayed repolarization, JLN syndrome is distinguished by autosomal recessive inheritance, congenital deafness, and a dramatically higher arrhythmic risk. Early diagnosis, genotype-guided therapy, and family screening remain the cornerstones of improving outcomes in both conditions.


For more cardiology articles and infographics visit:

drmusmanjaved.com



Comments

Popular posts from this blog

STEMI ECG Criteria and Universal Definition of MI

  STEMI ECG Criteria and the Universal Definition of Myocardial Infarction: A Complete Guide for Clinicians Early and accurate diagnosis of acute myocardial infarction (AMI) remains the cornerstone of reducing morbidity and mortality in patients presenting with chest pain. Among all forms of acute coronary syndromes (ACS), ST-elevation myocardial infarction (STEMI) represents the most time-sensitive emergency, requiring immediate reperfusion therapy. This article provides a clinically relevant summary of the STEMI ECG criteria and the Universal Definition of Myocardial Infarction (UDMI), based on the latest consensus guidelines from the ESC, ACC, AHA, and WHF. --- 1. Understanding STEMI: Why Accurate ECG Interpretation Matters A 12-lead ECG remains the first and most critical diagnostic test when evaluating suspected myocardial infarction. STEMI is identified when there is evidence of acute coronary artery occlusion, producing transmural ischemia and characteristic ST-segment eleva...

π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š

 π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.

2025 AHA/ACC Hypertension Guidelines Key points

  2025 AHA/ACC Hypertension Guidelines Explained: A Clear Summary for Clinicians and Students Hypertension remains one of the most significant contributors to cardiovascular morbidity and mortality worldwide. With continual refinement of evidence and risk-based strategies, the 2025 AHA/ACC Hypertension Guidelines bring an updated, practical approach that clinicians can use in daily practice. To make learning easier, I’ve created a clean and modern infographic summarizing all major recommendations. You can download it below and use it for study, teaching, or clinical reference. Download Infographic (PNG): 2025 Hypertension Guideline Infographic This post breaks down the key points from the guidelines and complements the infographic for a complete understanding. --- BP Categories: Understanding the Updated Thresholds The guidelines maintain the well-established classification of blood pressure: Normal: <120 / <80 Elevated: 120–129 / <80 Stage 1 Hypertension: 130–139 and/or 8...